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Introduction
Eukaryotic cell cycle progression requires faithful DNA dupli-
cation  and  division  of  the  chromosomes  between  daughter 
cells. These processes are tightly controlled and require mas-
sive restructuring of chromatin, which primarily consists of 
DNA repetitively wrapped around histone cores (Margueron 
and Reinberg, 2010). Posttranslational modifications of his-
tones by phosphorylation, acetylation, methylation, and ubiq-
uitylation are involved in the regulation of processes such as 
DNA replication, mitosis, DNA damage signaling, and repair 
(Kouzarides,  2007).  Certain  modifications  can  change  the 
compaction of chromatin and thereby the accessibility of the 
surrounding  DNA.  Histone  modifications  can  also  serve  as 
docking sites for effector proteins. Several proteins have been 
implicated in recognition of specific histone modifications   
that can facilitate recruitment of effector protein complexes   
to chromatin, where they elicit their cellular functions (Kouzarides, 
2007). A well-characterized example of this is the dynamic   
phosphorylation of Ser139 in histone H2AX (H2AX; Rogakou   
et al., 1998). This phosphorylation occurs near sites of DNA 
double-strand  break  lesions  and  is  catalyzed  by  the  ATM, 
DNA-PK, and ATR kinases. H2AX recruits the key DDR   
protein MDC1, which subsequently facilitates the localization 
of a number of effector proteins to the sites of DNA damage 
(Jackson and Bartek, 2009).
Another  highly  dynamic  chromatin  modification  is  the 
methylated form of histone H4 lysine 20 (H4K20; Margueron 
and Reinberg, 2010). This residue can be mono-, di-, and tri-
methylated. Monomethylation (H4K20me1) is catalyzed by the 
histone methyltransferase SET8 (Fang et al., 2002; Nishioka   
et al., 2002). SET8 plays a critical role in cell cycle progression, 
as its depletion in mammalian cells leads to aberrant progres-
sion through mitosis, DNA condensation failure, and slow progres-
sion through S phase accompanied by massive DNA damage 
(Jørgensen et al., 2007; Tardat et al., 2007; Houston et al., 2008; 
T
he  eukaryotic  cell  cycle  is  regulated  by  multiple 
ubiquitin-mediated  events,  such  as  the  timely  de-
struction of cyclins and replication licensing factors. 
The  histone  H4  methyltransferase  SET8  (Pr-Set7)  is  re-
quired  for  chromosome  compaction  in  mitosis  and  for 
maintenance of genome integrity. In this study, we show 
that SET8 is targeted for degradation during S phase by 
the CRL4(CDT2) ubiquitin ligase in a proliferating cell nu-
clear antigen (PCNA)–dependent manner. SET8 degra-
dation requires a conserved degron responsible for its 
interaction  with  PCNA  and  recruitment  to  chromatin 
where ubiquitylation occurs. Efficient degradation of SET8 
at the onset of S phase is required for the regulation of 
chromatin compaction status and cell cycle progression. 
Moreover, the turnover of SET8 is accelerated after ultra-
violet irradiation dependent on the CRL4(CDT2) ubiquitin 
ligase and PCNA. Removal of SET8 supports the modula-
tion of chromatin structure after DNA damage. These re-
sults demonstrate a novel regulatory mechanism, linking 
for the first time the ubiquitin–proteasome system with rapid 
degradation of a histone methyltransferase to control   
cell proliferation.
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Figure 1.  CRL-CDT2 targets SET8 for degradation in S phase. (A) SET8 protein level is low in S phase. U2-OS cells were treated with aphidicolin for 24 h   
and released for 4 h. The indicated cells were treated with MG132 1 h before harvest. Cells were processed for immunoblotting with the indicated anti-
bodies. Vinculin was used as a loading control. Async, asynchronous control cells. Protein levels of SET8 are quantified and depicted below the figure. (B) SET8 
contains a conserved PIP box degron. Cluster alignment of SET8 from different species show a highly conserved stretch of amino acids. When this stretch 
was aligned with CDT1 and p21, it revealed a conserved PIP box degron. (C) SET8 is mutually exclusive with PCNA and CDT2 on chromatin. U2-OS cells 
were synchronized with nocodazole, released into fresh medium, and collected at the indicated time points. Chromatin-bound fractions and whole cell 
extracts (WCE) were analyzed by immunoblotting with the indicated antibodies. (D) DDB1 and CDT2 depletion stabilizes SET8. U2-OS cells were treated 
with the indicated siRNAs 12 h before aphidicolin treatment. 24 h after aphidicolin treatment, cells were washed and released into fresh medium for   
3 h and processed for immunoblotting with the indicated antibodies. Actin was used as a loading control. (E) CDT2 is important for the turnover of SET8 45 CRL4(CDT2) targets SET8 for degradation • Jørgensen et al.
the target protein to chromatin via a PCNA-interacting motif 
(PIP box) in which the protein becomes ubiquitylated in situ by 
chromatin-bound CRL4(CDT2) (Havens and Walter, 2009).   
In mammalian cells, the only other known target of CRL4(CDT2) 
is the Cdk inhibitor p21, whose destruction facilitates repair of 
UV lesions and limits overreplication of the genome (rereplica-
tion; Abbas et al., 2008; Kim et al., 2008; Nishitani et al., 2008). 
In addition, transcription factor E2F1 and DNA polymerase Eta 
have been shown to be targeted by CRL4(CDT2) in Drosophila 
melanogaster and Caenorhabditis elegans, respectively (Kim 
and Michael, 2008; Shibutani et al., 2008). CDT2 plays impor-
tant roles in the regulation of cell cycle progression (Jin et al., 
2006; Liu et al., 2007), and it is essential for mouse embryonic 
development (Liu et al., 2007).
To obtain further insight into how the chromatin status   
is coordinated with cell cycle progression, we investigated the 
biological regulation of SET8 in mammalian cells. In this study, 
we show that SET8 ubiquitylation and degradation in S phase 
and UV-irradiated cells are dependent on CRL4(CDT2). SET8 
interacts with PCNA via a conserved PIP box, and this inter-
action is required for CRL4(CDT2)-dependent ubiquitylation. 
The ability to degrade SET8 under these conditions is critical to 
allow progression into mitosis. Furthermore, elevated SET8 in-
duces unscheduled chromatin compaction, which is dependent 
on its methyltransferase activity. Our data reveal SET8 as the 
first methyltransferase to be tightly regulated by the ubiquitin 
proteasome system and highlights the key importance of this 
system in securing orderly cell cycle progression.
Results
CRL4(CDT2) targets SET8 for degradation 
in S phase
To understand the mechanisms underlying the S phase–specific 
regulation of SET8, we treated U2-OS cells with the DNA poly-
merase inhibitor aphidicolin, which induces an early S phase 
arrest. 24 h later, cells were released and allowed to progress into 
mid–S phase, where SET8 protein level was very low (Fig. 1 A 
and Fig. S1 A). Treatment of cells with the proteasomal in-
hibitor MG132 resulted in stabilization of SET8 after aphidi-
colin treatment and in cells released into S phase from the 
aphidicolin block (Fig. 1 A). This result indicates a role for 
proteasomal  degradation  in  the  regulation  of  SET8  protein 
levels. To understand how SET8 turnover is regulated, we 
scanned the amino acid sequence of SET8 searching for motifs 
that could support regulated proteolysis. The analysis revealed 
a conserved PIP box degron (PIP box is a motif that mediates 
PCNA interaction), which is also found in the CDT2 targets 
CDT1 and p21 (Havens and Walter, 2009). This finding could 
indicate  an  involvement  of  the  CRL4(CDT2)  E3  ubiquitin   
ligase in the degradation of SET8 (Fig. 1 B). To analyze this 
Huen et al., 2008; Oda et al., 2009). Similar observations were 
made in a genetic mouse model (Oda et al., 2009), in which 
SET8 deletion leads to early embryonic lethality (Huen et al., 
2008; Oda et al., 2009). The phenotypes after loss of SET8 
could be rescued by wild type (WT) but not a catalytically in-
active version, suggesting that the methylation of H4K20 or   
additional targets is critical for cell cycle progression (Jørgensen   
et al., 2007; Tardat et al., 2007; Houston et al., 2008; Huen   
et al., 2008; Oda et al., 2009). The abundance of H4K20me1 is 
highly cell cycle regulated, being low in S phase and high in 
mitosis, a behavior that follows SET8 expression (Rice et al., 
2002). This mark has been associated with chromatin conden-
sation processes, which may be mediated in part by its direct   
recruitment of the MBT domain protein L3MBTL1 that can 
mediate compaction (Trojer et al., 2007). Monomethylated 
H4K20me1 can subsequently be di- (H4K20me2) and trimethyl-
ated (H4K20me3), which are triggered by the histone methyl-
transferases SUV4-20h1/2 (Schotta et al., 2008; Margueron and 
Reinberg, 2010). H4K20me3 has been reported to be directly 
involved in chromatin compaction, as the mark can induce a 
condensed chromatin state in vitro (Lu et al., 2008).
A key regulatory mechanism of cell cycle progression is 
ubiquitin-mediated proteolysis (O’Connell and Harper, 2007). 
This process involves the transfer of ubiquitin to lysine residues 
on the target protein by an E3 ubiquitin ligase that also mediates 
the substrate specificity of the ligase. Upon polyubiquitylation, 
the targeted proteins are degraded by the 26S proteasome 
(O’Connell and Harper, 2007). The cullin4 E3 ubiquitin ligases 
belong to a major subfamily of RING-H2 ubiquitin ligases that 
share a common architecture. The cullin subunit, CUL4A or 
CUL4B, associates with a common adapter protein, DDB1 
(damage-specific DNA-binding protein 1), which mediates the 
interaction with the substrate receptor proteins known as DDB1/
CUL4-associated  factors  (DCAFs;  O’Connell  and  Harper, 
2007; Jackson and Xiong, 2009). More than 50 DCAFs have 
been identified, allowing CUL4 E3s to regulate a large number 
of proteins and biological processes, such as cell cycle progres-
sion and the DNA damage responses to UV radiation (Jackson 
and Xiong, 2009). Mutations in two DCAFs, DDB2 and CSA, 
are associated with the human diseases Xeroderma pigmentosum 
and  Cockayne  Syndrome.  Both  of  these  disorders  display   
defects in UV repair by the nucleotide excision repair mecha-
nism, which is characterized by severe sensitivity to UV sun-
light (Fousteri and Mullenders, 2008; Stoyanova et al., 2009). 
After UV irradiation and during S phase of the cell cycle, the 
DCAF CDT2 is also an important CUL4 E3 ligase. The CDT2 
ubiquitin ligase is termed CRL4(CDT2), and it promotes the 
ubiquitylation and degradation of the replication factor CDT1 
in a process that requires the interaction with proliferating cell 
nuclear antigen (PCNA; Zhong et al., 2003; Jin et al., 2006; 
Senga et al., 2006; Havens and Walter, 2009). PCNA recruits 
in S phase. U2-OS cells were treated with siRNA 12 h before aphidicolin treatment. 24 h after aphidicolin treatment, cells were washed and released into 
fresh medium for 3 h. Cells were then treated with cycloheximide (CHX) as indicated and processed for immunoblotting with the indicated antibodies. The 
blots were quantified using an image reader. Representative data from three similar experiments are shown. Data are presented as mean + SD. (F) SET8 is 
ubiquitylated in vivo mediated by CDT2. HEK293 cells were depleted for CDT2 using siRNA 12 h before transfection with Flag-HA-SET8 and HIS-ubiquitin 
(HIS-UBQ) as indicated. Cells were processed for immunoprecipitation using cobalt beads and immunoblotted with the indicated antibodies.
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performed  a  cycloheximide  chase  experiment  to  investigate 
whether the PIP boxes were involved in the stabilization of 
SET8. Mutation of the second PIP box (*PIP2) resulted in   
increased stability of SET8 compared with WT, whereas mutation 
of the first, more N-terminal PIP box (*PIP1) did not alter the 
stability of SET8 (Fig. 2 B). Consistent with this result, we ob-
served that the interaction between SET8 and PCNA is highly 
dependent on the PIP2 but not the PIP1 motif (Fig. S1 H). Further-
more, a deletion version of SET8 (aa 1–180) containing PIP1 but 
not PIP2 was also stable (unpublished data). We next investigated 
whether PCNA was involved in the turnover of SET8. Expres-
sion of exogenous PCNA was found to decrease the level of   
WT SET8 but not the SET8-*PIP2 mutated version (Fig. 2 C). 
To determine whether the increased stability of SET8-*PIP2 
was caused by lack of polyubiquitylation, we performed a SET8 
in vivo ubiquitylation assay. We found that polyubiquitylation 
of SET8-*PIP2 was very much reduced compared with WT 
SET8 (Fig. 2 D).
To further understand the interplay between SET8 and 
PCNA, we investigated the localization of ubiquitylated SET8. 
U2-OS cells were treated with MG132 and chromatin fraction-
ated, and we observed that endogenous SET8 is primarily poly-
ubiquitylated on chromatin, as indicated by the appearance of 
high molecular mass SET8 species (Fig. 2 E). Finally, we inves-
tigated whether SET8 and PCNA were localizing to the same 
areas in the cell using immunofluorescence. We stabilized exog-
enous SET8 with MG132, and, consistent with the findings in 
cell lysates, we could clearly detect colocalization of PCNA and 
SET8 WT  but  not  PCNA  and  SET8-*PIP2  in  U2-OS  cells. 
SET8-*PIP2 also localized to chromatin (Fig. S1 I); however, 
this version was not colocalizing with PCNA as clearly as   
wt-SET8 (Fig. 2 F). In conclusion, PCNA is important for the 
protein turnover of SET8 on chromatin, and the PIP2 motif is   
a functional PIP degron required for polyubiquitylation and 
degradation of SET8.
SET8 turnover is accelerated after  
UV damage
CRL4(CDT2) plays dual roles in protein degradation being   
active in S phase and after DNA damage (O’Connell and Harper, 
2007). We therefore wished to investigate whether SET8 ac-
cumulation was affected by DNA damage. We treated cells 
with increasing dosages of UV and found that SET8 protein 
level was reduced in response to the irradiation (Fig. 3 A). 
H4K20me1 levels were also reduced by UV damage. To cor-
roborate these findings, we performed a kinetics study using   
a fixed dosage of UV and observed that SET8 protein levels 
declined over time (Fig. 3 B). This was not because of UV- 
induced cell cycle alterations (Fig. S2, A and B), as only the 24-h 
time point was markedly affected. Consistently, H4K20me1 
levels were also reduced after UV treatment, but with a slower 
kinetic than SET8, suggesting that this might be caused by loss 
of the methyltransferase. Similar data were obtained after ion-
izing radiation (IR), although SET8 degradation appeared less 
efficient than after UV treatment (Fig. S2, C and D). We also 
observed UV-mediated SET8 degradation in diploid human   
fibroblasts (Fig. S2 E).
aspect,  we  performed  cell  cycle  synchronization  assays  to 
study the behavior of SET8, CDT2, and PCNA. We synchro-
nized U2-OS cells in mitosis with the spindle inhibitor no-
codazole, and cells were then released and collected through 
G1 and S phase. When we analyzed protein abundance on chro-
matin, it became obvious that SET8 was very low in S phase, 
which inversely correlated with the chromatin localization of 
PCNA and CDT2 (Fig. 1 C).
These data further indicated a role for CDT2 and PCNA in 
the control of SET8 accumulation on chromatin. We therefore 
depleted DDB1 and CDT2, two members of the CRL4(CDT2) 
E3 ubiquitin ligase complex (Jackson and Xiong, 2009). The 
siRNA treatments led to a marked increase in SET8 protein   
levels (Fig. 1 D). This result was confirmed for CDT2 siRNA   
in human diploid fibroblasts (Fig. S1 B).
To investigate whether CDT2 is involved in the turnover 
of SET8, U2-OS cells were depleted for CDT2 using siRNA, 
immediately followed by synchronization with aphidicolin and 
release into mid–S phase. As a measure of protein turnover, 
cells were treated with cycloheximide to inhibit protein synthe-
sis and processed for immunoblotting. Although SET8 was un-
stable in control siRNA-treated cells, CDT2 depletion markedly 
increased the half-life of SET8 (Fig. 1 E). This was confirmed 
using a second siRNA targeting CDT2 (Fig. S1 C). Similar sta-
bilization  of  SET8  was  observed  upon  depletion  of  DDB1   
and PCNA (Fig. S1, D and E). More efficient PCNA depletion   
could possibly further stabilize SET8; however, we deliberately 
chose partial PCNA depletion to avoid the severe cellular con-
sequences of PCNA depletion (Moldovan et al., 2007). We ob-
tained similar results on SET8 stability with two independent 
siRNAs targeting PCNA. CDT2 depletion has previously been 
shown to arrest cells in G2 phase, but our synchronization setup 
allowed cells to progress proficiently through S phase within 
the experimental timeframe (Fig. S1 F). In addition, we also ob-
served largely similar cell cycle profiles in the presence and ab-
sence of cycloheximide treatment (Fig. S1 G). To investigate 
whether SET8 was targeted for polyubiquitylation in a CDT2-
dependent manner, we expressed SET8 together with histidine-
tagged ubiquitin (HIS-Ubi). Ubiquitylated proteins were purified 
via the HIS tag, and we observed marked polyubiquitylation   
of SET8. Importantly, this was very much reduced after CDT2 
depletion using siRNA (Fig. 1 F). All together, we found that 
SET8 is a target for proteasomal degradation in S phase and that 
the degradation is mediated via the CRL4(CDT2) ubiquitin li-
gase complex.
The interaction between PCNA and 
SET8 is important for CDT2-mediated 
degradation of SET8
PCNA plays a major role in CRL4(CDT2)-mediated ubiquity-
lation and degradation, which is dependent on the PIP box de-
gron in target proteins (Havens and Walter, 2009). We previously 
identified a functional PIP box in SET8 (Jørgensen et al., 2007); 
however, another more N-terminal PIP box has also been identi-
fied (Huen et al., 2008). Both PIP boxes are N-terminal to the 
SET domain, which contains the enzymatic activity as depicted 
in Fig. 2 A. We mutated the two published PIP box motifs and 47 CRL4(CDT2) targets SET8 for degradation • Jørgensen et al.
damage–induced cell cycle arrest blocking entry into mitosis, 
where the SET8 protein level is high. To investigate whether the 
turnover of SET8 was accelerated after UV treatment in S phase, 
we performed cycloheximide chase experiments. We released 
aphidicolin-synchronized cells into S phase and treated them 
with cycloheximide or a combination of cycloheximide and UV. 
We found that addition of UV irradiation resulted in an acceler-
ated degradation of SET8 in S phase (Fig. 3 E).
Next, we investigated whether the damage-mediated re-
moval of SET8 was dependent on proteasomal degradation. We 
treated cells with a combination of UV and MG132, and al-
though SET8 was unstable after UV treatment, the addition of 
MG132 rescued SET8 protein levels after UV (Fig. 3 C). Similar 
data were observed using immunofluorescence after UV treat-
ment (Fig. 3 D) and IR (Fig. S2 F). It remained a possibility that 
the observed reduction in SET8 levels was a consequence of DNA 
Figure 2.  The interaction between PCNA and SET8 is important for CDT2-mediated degradation of SET8. (A) Schematic presentation of SET8. Two PIP 
boxes (PCNA-interacting domains) have been identified N terminally to the SET domain. (B) Mutation of PIP2 results in stabilization of SET8. HEK293 
cells were transfected with plasmids expressing Flag-HA-SET8, Flag-HA-SET8-*PIP1, and Flag-HA-SET8-*PIP2. Cells were treated with cycloheximide and 
processed for immunoblotting with the indicated antibodies. MCM7 was used as a loading control. (C) Increased levels of PCNA result in degradation of 
WT SET8 but not SET8-*PIP2. HEK293 cells were transfected as illustrated and processed for immunoblotting with the indicated antibodies. (D) In vivo ubiq-
uitylation of SET8-*PIP2 is reduced compared with SET8 WT. HEK293 cells were transfected with Flag-HA-SET8, Flag-HA-SET8-*PIP2, and HIS-ubiquitin as 
indicated. Cells were processed for immunoprecipitation using cobalt beads and immunoblotted with the indicated antibodies. (E) SET8 is ubiquitylated on 
chromatin. U2-OS cells were either treated with MG132 for 3 h or left untreated. Soluble and chromatin-bound fractions were analyzed by immunoblotting 
with SET8 antibody. *, nonspecific band. (F) SET8 WT and PCNA colocalize on chromatin after MG132 treatment. U2-OS cells expressing Flag-HA-SET8 
or Flag-HA-SET8-*PIP2 were seeded on coverslips and treated with MG132 for 3 h before preextraction and fixation. Cells were stained with antibodies 
against HA and PCNA. Bars, 10 µm.JCB • VOLUME 192 • NUMBER 1 • 2011   48
these results with a second siRNA targeting CDT2 (Fig. S2 G), 
and SET8 was also stabilized when we depleted DDB1 and 
PCNA (Fig. S2, H and I). Furthermore, we wished to investigate 
whether UV treatment would affect the ubiquitylation of SET8. 
In vivo ubiquitylation assays showed that UV irradiation re-
sulted in increased polyubiquitylation of SET8 that could be 
further increased by a combination of UV and MG132 (Fig. 4 C). 
In marked contrast, depletion of CDT2 reduced polyubiquity-
lation of SET8, and proteasomal inhibition with MG132 could 
To investigate whether the UV-induced degradation was 
dependent on CDT2, we knocked the protein down in U2-OS 
cells using siRNA and treated cells with UV. This revealed that 
CDT2 depletion increased SET8 level after UV (Fig. 4 A). Next, 
we wanted to analyze SET8 protein level in CDT2-depleted 
cells that had been released into S phase from aphidicolin syn-
chronization in more details. After treatment with a combina-
tion of cycloheximide and UV, we found that depletion of CDT2 
led to an increased half-life of SET8 (Fig. 4 B). We confirmed 
Figure 3.  SET8 turnover is accelerated after UV damage, and SET8 is degraded after UV. (A) U2-OS cells were treated with increasing amounts of UV 
damage and processed for immunoblotting 3 h after treatment as indicated. (B) U2-OS cells were treated with a fixed dose of UV, harvested at the indicated 
time points, and processed for immunoblotting. (C and D) Proteasomal inhibition blocks SET8 degradation. (C) U2-OS cells were treated with UV alone or a 
combination of UV and MG132 for 1 h. Cells were processed for immunoblotting and quantitative PCR as indicated. Data are represented as mean + SD.   
(D) U2-OS cells were infected with an HA-SET8–expressing virus and seeded onto coverslips. Cells were treated with MG132, UV, or a combination   
6 h before fixation and harvest. Coverslips were processed for immunofluorescence with the indicated antibodies. The remaining cells were processed 
for immunoblotting with the indicated antibodies. Bars, 10 µm. (E) UV treatment accelerates degradation of SET8. U2-OS cells were synchronized using 
aphidicolin and release into S phase, where they were treated with cycloheximide or a combination of cycloheximide and UV as indicated. Cells were 
processed for immunoblotting with the indicated antibodies.49 CRL4(CDT2) targets SET8 for degradation • Jørgensen et al.
Figure 4.  CRL4(CDT2) targets SET8 for degradation after UV. (A) CDT2 depletion stabilizes SET8 after UV. U2-OS cells were depleted for CDT2 and 
synchronized with aphidicolin. Cells were released into mid–S phase and treated with UV, harvested after 2 h, and processed for immunoblotting with 
the indicated antibodies. (B) Knockdown of CDT2 decreases SET8 turnover after UV. U2-OS cells were treated with siRNA 12 h before aphidicolin treat-
ment. 24 h after aphidicolin treatment, cells were washed and released into fresh medium for 3 h. Cells were then treated with cycloheximide and UV as 
indicated and processed for immunoblotting with the indicated antibodies. The blots were quantified using an image reader. This is representative data 
from three similar experiments. Data are presented as mean + SD. (C) UV increases in vivo ubiquitylation of SET8. HEK293 cells were depleted for CDT2 
using siRNA 8 h before transfection with Flag-HA-SET8 and HIS-ubiquitin as indicated. Cells were treated with UV or a combination of UV and MG132   
2 h before harvest followed by immunoprecipitation using cobalt beads and immunoblotted with the indicated antibodies. (D) Mutation of PIP2 but not PIP1 
increases stability of SET8 after UV. HEK293 cells were transfected with either Flag-HA-SET8, -*PIP1, or -*PIP2. They were treated with a combination of 
cycloheximide and UV or cycloheximide, UV, and MG132. Cells were processed for immunoblotting with the indicated antibodies. (E) WT SET8 but not 
SET8-*PIP2 is ubiquitylated in vivo after UV treatment. Cells were transfected with Flag-HA-SET8, Flag-HA-SET8-*PIP2, and HIS-ubiquitin as indicated. Cells 
were processed for immunoprecipitation using cobalt beads and immunoblotted with the indicated antibodies.JCB • VOLUME 192 • NUMBER 1 • 2011   50
investigated how expression of various mutant forms of SET8   
affected  chromatin  compaction.  Cells  expressing  SET8-*PIP2   
and elevated levels of WT SET8 could induce marked chro-
matin compaction in cells released from aphidicolin arrest.   
This  phenotype  was  dependent  on  the  methyltransferase   
activity,  as  catalytically  inactive  SET8  versions  had  little   
effect on chromatin compaction (Fig. 5 C and Fig. S3 E).   
In agreement with this, we observed that chromatin was in a 
more-compacted state, as indicated by reduced MNase cleav-
age  in  SET8-*PIP2–expressing  cells  compared  with  cells  ex-
pressing SET8-*PIP2/*SET (Fig. 5 D and Fig. S3 F). Similar 
data were obtained when comparing MNase digest from cells 
expressing wt-SET8 and SET8-*SET (Fig. S3 G). Finally, we 
wished to investigate the chromatin status of UV-treated cells 
expressing  SET8-*PIP2  compared  with  SET8-*PIP2/*SET 
using a MNase digest. In line with the aforementioned data, 
we observed that expression of SET8-*PIP2 resulted in a 
more  compact  chromatin  structure  compared  with  SET8-
*PIP2/*SET also after UV treatment (Fig. 5 E and Fig. S3 H). 
In conclusion, we propose that SET8 is a target of ubiquity-
lation and proteasomal degradation to allow a flexible state 
of chromatin that facilitates chromatin modulation during 
the cell cycle.
Discussion
In this study, we discovered how cells control the ubiquitylation 
and degradation of the H4K20 methyltransferase SET8, a key 
regulator of cell cycle progression and genome integrity (Oda   
et al., 2009; Yang and Mizzen, 2009). It was established that 
SET8 levels oscillate during the cell cycle, being low in S phase 
and high in mitosis (Rice et al., 2002). We now show that the 
CRL4(CDT2) E3 ubiquitin ligase promotes ubiquitylation and 
subsequent degradation of SET8 dependent on a conserved PIP 
box degron. In cells depleted of DDB1, CDT2, or PCNA, the 
degradation and ubiquitylation of SET8 were impaired. This 
proteolysis of SET8 is important because its impairment affects 
cell cycle progression at the G2/M transition. Remarkably, 
CDT2 depletion also induces a G2 arrest, and this further sug-
gests a close linkage between the CRL4(CDT2) ubiquitin   
ligase and SET8 turnover. We therefore propose that PCNA-
CRL4(CDT2) is required to degrade SET8 when PCNA loads 
on chromatin at the G1/S transition (Fig. 1 C). Endogenous 
levels of SET8 clearly do not exceed the capacity of PCNA-
CRL4(CDT2), and we noted that cells have high capacity to 
degrade SET8.
Most cells expressing the SET8-*PIP2 version were able 
to enter S phase even when the protein was expressed at a high 
level from a cytomegalovirus promoter. We did not observe   
aberrant S phase progression (Fig. S3 A), and these cells accu-
mulated in G2 phase. PCNA-CRL4(CDT2) is also required in   
S phase to promote the ubiquitylation and degradation of the 
Cdk inhibitor p21 (Abbas et al., 2008; Kim et al., 2008; Nishitani   
et al., 2008) and the replication licensing factor CDT1 (Zhong 
et al., 2003; Jin et al., 2006; Senga et al., 2006). Elevated levels of 
CDT1 did not block replication; rather, its PCNA-CRL4(CDT2)–
mediated proteolysis served to prevent overreplication of the 
not rescue this (Fig. 4 C). To investigate whether PIP boxes   
affected the UV-mediated degradation of SET8, we performed 
cycloheximide chase experiments including the two PIP box 
mutants and WT SET8. Although both WT and SET8-*PIP1 
were unstable after the combined cycloheximide and UV treat-
ment, the SET8-*PIP2 version was stable (Fig. 4 D). Finally, we 
performed an in vivo ubiquitylation assay, which revealed that 
SET8-*PIP2 cannot be efficiently polyubiquitylated in response   
to UV irradiation. WT SET8 was efficiently polyubiquitylated 
in response to UV (Fig. 4 E). In conclusion, SET8 is degraded 
by the proteasome in response to UV irradiation, a degradation 
mediated via CDT2 and PCNA-dependent ubiquitylation.
Degradation of SET8 allows cell cycle 
progression beyond G1 phase
To investigate the biological relevance of the oscillating level of 
SET8 protein through the cell cycle, we performed flow cytom-
etry analysis of cells expressing WT and mutant forms of SET8. 
We used a mitotic trap with the spindle inhibitor nocodazole to 
evaluate whether cells were able to proceed into mitosis (Fig. 5 A). 
WT SET8 expressed from a weak promoter is subjected to pro-
teolysis, and as a consequence, the protein level was oscillating 
and present at a lower level than the nondegradable SET8-*PIP2 
(Fig. 5 B). We observed that cells expressing WT and catalyti-
cally inactive SET8 behaved almost as control cells regarding 
their progression through the cell cycle into mitosis (Fig. 5 A). 
In contrast, expression of nondegradable SET8-*PIP2 markedly 
affected cell cycle progression, as very few cells entered mito-
sis in the experimental setup (Fig. 5 A). Importantly, the non-
degradable and catalytically inactive SET8-*PIP2/*SET mutant   
did not disturb cell cycle progression in the course of the ex-
periment. This indicates that SET8 levels are reduced by prote-
olysis during S phase to avoid unscheduled methyltransferase 
activity in S and G2 phase. As positive control, we expressed   
elevated levels of WT SET8 saturating the degradation ca-
pacity, and as expected, this also blocked cell cycle progres-
sion into mitosis (Fig. 5 A). Importantly, flow cytometry analysis 
of cells expressing SET8-*PIP2 and SET8-*PIP2/*SET did 
not  reveal  alterations  in  progression  through  S  phase  when 
compared with control cells (Fig. S3 A). We did not observe 
checkpoint activation upon expression of nondegradable SET8, 
as assayed by immunoblotting (Fig. S3 B) or flow cytometry 
(Fig. S3 C). We also investigated the consequences of stable 
SET8 expression by analyzing the fitness of these cells in clono-
genic survival assays. In agreement with the cell cycle progres-
sion defect, SET8-*PIP2–expressing cells formed few colonies 
in clonogenic survival assays, whereas cells expressing the   
catalytically  inactive  SET8-*PIP2/*SET  version  displayed   
better fitness in this assay (Fig. S3 D). We were not able to properly 
address the survival of cells expressing SET8-*PIP2 after UV 
treatment because these cells performed poorly in clonogenic 
survival assays even in the absence of UV treatment (Fig. S3 D).
Data  from  several  model  systems  including  SET8 
knockout mice have shown that deletion of SET8 results in 
reduced chromatin compaction (Houston et al., 2008; Oda   
et al., 2009). We reasoned that the degradation of SET8 could 
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It  is  remarkable  that  PCNA  plays  a  unique  role  in 
CRL4(CDT2)-mediated ubiquitylation processes. Recently, 
CDT1 ubiquitylation via CRL4(CDT2) has been clarified, and 
it was apparent that the docking of CDT1 onto chromatin-bound 
PCNA via the PIP degron generates a signal for recruiting the 
CRL4(CDT2) ligase and, ultimately, CDT1 ubiquitylation and 
destruction (Havens and Walter, 2009). A similar mechanism is 
likely to operate for SET8, which we identified in this study, 
genome (Jin et al., 2006). However, we have not observed re-
replication in experiments with elevated or nondegradable SET8 
(unpublished data). Given that SET8-*PIP2–expressing cells 
can replicate efficiently, we expect that these G2-arrested cells 
can eventually initiate rereplication reaching >4 N DNA content 
without intervening mitosis. However, this will be a delayed sec-
ondary event relative to the rapidly occurring issues described 
in this study.
Figure 5.  Degradation of SET8 allows cell cycle progression beyond G1 phase. (A) Nondegradable SET8 reduces entry into mitosis. U2-OS cells were 
cotransfected with H2B-GFP and the indicated Flag-HA-SET8 constructs in a 1:3 ratio and simultaneously treated with aphidicolin for 24 h. Cells were 
released into fresh medium containing nocodazole, harvested, and fixed at the indicated time points. Cells were stained with H3S10P antibody, and cells 
positive for both GFP and H3S10P were identified by flow cytometry. Data are presented as mean + SD. (B) Expression levels of SET8 constructs. U2-OS 
cells were treated with nocodazole for 16 h (Noco) or transfected with the indicated pBabe or pCMV constructs 36 h before harvest. Cells were processed 
for immunoblotting with the indicated antibodies. Only 0.1 of the pCMV SET8 WT lysate was loaded compared with pBabe SET8 lysates. (C) SET8 WT 
and SET8-*PIP2 expression induces compaction of chromatin. pCMV Flag-HA-SET8 constructs were expressed in U2-OS cells seeded on coverslips and 
simultaneously treated with aphidicolin for 24 h. Cells were released into fresh medium and fixed after 4 h. Chromatin structure in SET8-expressing cells 
was analyzed by immunofluorescence stainings for DAPI in HA-positive cells. Bars, 10 µm. (D) Elevated levels of SET8-*PIP2 but not SET8-*PIP2/*SET 
results in a more compact chromatin structure. HEK293 cells were transfected with either Flag-HA-SET8-*PIP2 or Flag-HA-SET8-*PIP2/*SET constructs. Cells 
were harvested for MNase digest followed by separation of the DNA on an agarose gel. (E) Elevated levels of SET8-*PIP2 but not SET8-*PIP2/*SET results 
in a more compact chromatin structure in response to UV. HEK293 cells were transfected with either Flag-HA-SET8-*PIP2 or Flag-HA-SET8-*PIP2/*SET 
constructs. Cells were treated with UV (100 J/m
2) 3 h before harvest. Cells were harvested for MNase digest followed by separation of the DNA on an 
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Tardat et al., 2007; Houston et al., 2008; Huen et al., 2008;   
Oda  et  al.,  2009).  Experiments  performed  with  conditional 
SET8 knockout ES cells revealed that the cell cycle can progress 
through the first S and M phase without SET8, but catastrophic 
events occur in the following cell cycle where spontaneously 
arising DNA damage leads to checkpoint activation (Oda et al., 
2009). A very tightly regulated expression of SET8 is therefore 
critical to allow cells to proliferate productively and at the same 
time protect themselves against exogenously arising DNA dam-
age. Furthermore, we propose that the DNA damage–mediated 
reduction of SET8 is involved in relaxation of the chromatin 
structure, which is supported by our MNase digest data. This is 
reminiscent of the role of the transcriptional repressor KAP-1, 
whose depletion leads to chromatin relaxation and more effi-
cient DNA repair after IR (Ziv et al., 2006; Goodarzi et al., 2008). 
We do not exclude that nonhistone targets of SET8 can modulate 
the phenotypic outcome. As an example, SET8 has been shown 
to methylate a nonhistone protein, p53. The methylation was 
found to inhibit the transactivating activity of p53 on the target 
genes p21 and PUMA and thereby also part of the damage re-
sponse (Shi et al., 2007). We have however not been able to   
detect an effect of ectopic SET8 expression on p53 target genes 
in our cellular system (unpublished data).
All together, we propose that SET8 protein levels are 
kept low from the G1/S transition and during S phase by the 
CRL4(CDT2) ubiquitin ligase complex to support a chromatin 
structure that favors cell cycle progression. In addition, we sug-
gest that the CRL4(CDT2)-mediated degradation of SET8   
after UV treatment supports a chromatin structure that facili-
tates repair. Three recent studies also identified a role for 
PCNA-CRL4(CDT2)–mediated regulation of SET8 in cell cycle 
progression (Abbas et al., 2010; Centore et al., 2010; Tardat et al., 
2010). Centore et al. (2010) also observed marked chromatin 
compaction in SET8-expressing cells. Intriguingly, Abbas et al. 
(2010) observed some H2AX phosphorylation after SET8-*PIP2 
expression, whereas Centore et al. (2010) observed increased 
CHK1 phosphorylation (Abbas et al., 2010; Centore et al., 2010). 
We have not observed this in our experiments (Fig. S3, B and C), 
which may relate to different levels of SET8-*PIP2 expres-
sion between the three studies. Tardat et al. (2010) also observed 
H2AX phosphorylation; however, this was linked with DNA 
replication issues at later stages after SET8-*PIP2 expression 
(Tardat et al., 2010). The issue of genome integrity upon expres-
sion of stable SET8 is an important topic for future studies.
Materials and methods
Cell culture and chemicals
Human  U2-OS  osteosarcoma,  HEK293,  and  Tig3  TERT  cell  lines  were 
grown in DME with 10% fetal bovine serum. Nocodazole, cycloheximide, 
MG132, and aphidicolin were used at 100 ng/µl, 20 µg/ml, 5 µM, and 
4 µM, respectively (Sigma-Aldrich). IR was performed using an x-ray appa-
ratus (Faxitron X-Ray LLC) calibrated to give 1 Gy -irradiation for 2 min. 
UV was performed using a UV Stratalinker 1800 (AH Diagnostics).
Chromatin fractionation
To obtain soluble and chromatin-enriched cellular fractions, cell fraction-
ation was performed. In brief, cells were lysed for 30 min in a small volume 
of CSK buffer (0.5% Triton X-100, 10 mM Pipes, pH 6.8, 300 mM sucrose, 
100 mM NaCl, and 1.5 mM MgCl2). The lysed cells were pelleted by   
and p21. All three proteins are involved in cell cycle control   
and DNA replication, and their elevated levels will disturb   
these processes.
In contrast to SET8-*PIP2, cells expressing catalytically 
inactive SET8-*PIP2 were able to enter mitosis. Thus, the pres-
ence of SET8 methyltransferase activity during S and G2 phase 
leads to G2 arrest. Importantly, the expression of wt-SET8 and 
SET8-*PIP2 induced marked chromatin compaction, which is 
dependent on methyltransferase activity. These data support re-
cent studies identifying an important role of SET8 in chromo-
some condensation (Houston et al., 2008; Oda et al., 2009).   
Oda et al. (2009) showed that conditional knockout of SET8   
in mouse ES cells results in chromosomal decondensation   
of mitotic and in interphase nuclei. In line with this, SET8   
and H4K20me1 have been previously reported to induce chro-
matin  compaction  via  H4K20me1-dependent  recruitment  of 
L3MBTL1 (Trojer et al., 2007). We addressed the potential role 
of L3MBTL1 by depleting it in cells ectopically expressing 
SET8; however, L3MBTL1 depletion only had a minor effect 
on chromatin compaction (unpublished data). These findings 
are in line with a recent study showing absence of chromatin 
compaction phenotypes in L3MBTL1-deficient cells (Qin et al., 
2010). We favor the notion that L3MBTL1 and additional pro-
teins respond to elevated SET8 and H4K20 methylation states 
to alter chromatin structure. Very recently, monomethylated 
H4K20 was shown to specifically interact with condensin-II 
subunits, and this may also drive the unscheduled compaction 
of chromatin (Liu et al., 2010). Finally, structural experiments 
of the nucleosome revealed that trimethylated H4K20 could in-
crease the compaction of nucleosomal arrays, further suggest-
ing that the H4K20 residue is involved in chromatin compaction 
(Lu et al., 2008). Because of the inability to deplete and recon-
stitute with mutant versions of histone H4, we cannot address 
the role of H4K20 methylation directly in our experimental setup. 
However, our results are in agreement with the emerging data from 
Liu et al. (2010) suggesting that SET8-mediated monomethyl-
ation of histone H4 mediates chromatin compaction that sub-
sequently negatively affects cell cycle progression.
In this study, we also discovered that SET8 is actively de-
graded after UV radiation by polyubiquitylation. The E3 ligase 
that promotes the ubiquitylation in response to UV irradiation   
is also PCNA-CRL4(CDT2). Silencing components of the 
CRL4(CDT2) E3 ubiquitin ligase by siRNA not only elevated 
the basal levels of SET8, it also reduced SET8 degradation after 
UV (Fig. 4). To our knowledge, this is the first study in mam-
malian cells that identifies a regulated role of histone methyl-
transferase proteolysis in the DNA damage response. It is 
noteworthy that we did not observe a role for the checkpoint   
kinases ATR, ATM, or CHK1 in the regulation of SET8 turn-
over (negative data not depicted). This is similar to previous 
data on CDT1 and p21 destruction after DNA damage, and it 
may be the structural modulation of PCNA in areas with DNA 
lesions that accelerates the proteolysis of CDT2 targets.
SET8 has been previously linked with the DNA dam-
age response, as we and others have discovered that the de-
pletion of SET8 leads to loss of genomic integrity even in the   
absence of exogenous DNA damage (Jørgensen et al., 2007; 53 CRL4(CDT2) targets SET8 for degradation • Jørgensen et al.
cells were fixed in 70% ethanol and stained with rabbit H3S10P and 
mouse H2AX for 1 h. This was followed by 1-h incubation with conju-
gated anti–mouse IgG and anti–rabbit IgG (Alexa Fluor 488 and 647 at 
1:1,000). DNA was counterstained by 0.1 mg/ml propidium iodide sup-
plemented with RNase for 30 min at 37°C. Analysis was performed on a 
FACSCalibur using CellQuest software (BD). Profiles are based on GFP-
positive cells. Quantification and analysis of cell cycle profiles were ob-
tained using FlowJo (version 7.2.2; Tree Star, Inc.).
Micrococcoal nuclease digestion
Cells were transfected as indicated and harvested in cold PBS. Cells were 
then collected by centrifugation (300 g for 5 min at 4°C), and the pellet 
was resuspended in cytosolic lysis buffer (10 mM Tris-HCl, pH 7.5, 10 mM 
NaCl, 5 mM MgCl2, 0.5% NP-40, and 0.25 mM PMSF) and left on ice for 
8 min. Nuclei were pellet by centrifugation (500 g for 5 min at 4°C). The 
pellet was washed once in nuclei buffer (60 mM KCl, 15 mM NaCl, 0.34 M 
sucrose, 0.25 mM PMSF, and 1 mM DDT) and resuspended in nuclei buffer 
to a final absorbance at 0.1. 2 mM CaCl2 was added, and the samples 
were prewarmed to 25°C. Micrococcoal nuclease (1:1,000 U/µl; Sigma-
Aldrich) was added to the sample and incubated at 30°C for the indicated 
time period. The digest was stopped by addition of STOP buffer (0.7% SDS 
and 30 mM EDTA, pH 8). Genomic DNA was purified using a DNeasy 
Blood and Tissue kit (QIAGEN) and run on a 1% agarose gel. Pictures 
were acquired using a Gel Doc XR (Bio-Rad Laboratories).
Online supplemental material
Fig. S1 shows characterization of SET8 protein levels and cell cycle pro-
gression through S phase upon depletion of CDT2, DDB1, and PCNA. An 
interaction study between mutant forms of SET8 and endogenous PCNA 
and a cellular localization study of SET8-WT versus SET8-*PIP2 are also 
shown. Fig. S2 shows that DNA damage–mediated degradation of SET8 
can be rescued by addition of MG132 or depletion of CDT2, DDB1, or 
PCNA. Fig. S3 shows that expression of SET8-*PIP2 does not affect pro-
gression through S phase or lead to DNA damage up to 48 h after trans-
fection. It also shows that SET8-*PIP2 expression results in poor survival 
and compaction of chromatin. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.201009076/DC1.
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Immunoblotting and antibodies
Cells were lysed on ice in RIPA buffer followed by sonication (see previous 
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body diluted in 5% milk as indicated in Figs. 1–5 followed by incubation 
with secondary antibody (peroxidase-labeled anti–mouse or –rabbit IgG 
[1:10,000; Vector laboratories]). Films were developed using an x-ray   
machine (Valso; Ferrania). Immunoblots were quantified using an image 
reader (LAS-3000; Fujifilm) and analyzed using Image Gauge software 
(Fujifilm)  when  indicated.  Antibodies  to  MCM7  (DCS-141)  and  CHK1 
(DCS310) have been described previously (Sørensen et al., 2005). Com-
mercially available antibodies used in this study were cyclin A (sc-751) 
and rabbit (Y11) anti–HA tag (Santa Cruz Biotechnology, Inc.). Phospho-
CHK1 antibody (CHK1-pSer317; #23445) was purchased from Cell Sig-
naling  Technology.  Phosphorylated  H2AX  (05-636),  phosphorylated 
H3S10 (06-570), and SET8 (06-1304) were purchased from Millipore. 
Monomethylated H4 lysine20 (ab9051) was purchased from Abcam.   
Vinculin (V9131) was purchased from Sigma-Aldrich. PCNA (PC10) was 
purchased from Abnova, and CDT2 (NB-10-40840) was obtained from 
Novus Biologicals. The DDB1 antibody (34-2300) was purchased from   
Invitrogen, and actin (MAB1501) was purchased from Millipore. Fluorescence-
conjugated anti–mouse and anti–rabbit IgG were purchased from Invitrogen 
(Alexa Fluor 488 and 594; Table I).
In vivo ubiquitylation
Cells were lysed in ubiquitin lysis buffer (50 mM NaH2PO4, 300 mM 
NaCl, 5 mM imidazole, and 0.05% Tween 20 + inhibitors) and sonicated. 
Lysate was incubated with cobalt beads (His tag purification resins;   
Takara Bio Inc.) for 1 h at 4°C followed by 10 washes with ubiquitin wash 
buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, and 0.05% 
Tween 20 + inhibitors). Bound proteins were eluted in 500 mM imidaz-
ole, mixed with Laemmli sample buffer, and immunoblotted with the indi-
cated antibody.
Microscopy and immunofluorescence
Cells were grown on coverslips and treated as indicated in Figs. 1–5. The 
coverslips were washed briefly in PBS and fixed for 10 min with 4% para-
formaldehyde. Cells were permeabilized in PBS supplemented with 0.3% 
Triton X-100 for 10 min and incubated with primary antibodies in PBS sup-
plemented with 3% BSA for 1 h at room temperature. Cells were washed 
in PBS supplemented with 0.05% Tween 20 three times for 10 min and in-
cubated with Alexa Fluor 488– or 594–conjugated secondary antibodies 
(1:1,000; Invitrogen) for 1 h at room temperature. Cells were washed in 
PBS  supplemented  with  0.05%  Tween  20  three  times  for  10  min  and 
mounted  using  mounting  medium  containing  DAPI  (Vectashield;  Vector 
Laboratories) followed by confocal microscopy analysis. Pictures were ac-
quired at room temperature on an inverted microscope (Axiovert 200M 
LSM 510; Carl Zeiss, Inc.) using a 40× NA 1.2 c-Apochromat objective in 
H2O or a 63× NA 1.2 c-Apochromat objective in H2O. Pictures were ana-
lyzed using LSM 510 META software and LSM image examiner software 
(Carl Zeiss, Inc.). All pictures were exported in preparation for printing   
using Photoshop (Adobe).
Quantitation of mRNA levels by quantitative PCR
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was used as a control for normalization.
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Table I.  siRNA oligonucleotides used in this study
siRNA Sequence
CDT2 #1 5-GAAUUAUACUGCUUAUCGA-3
CDT2 #2 5-AUACAAGAGUGACUCUAUA-3
DDB1 #1 5-ACAGAGUGGCGAGAGCAUU-3
DDB1 #2 5-CCUGUUGAUUGCCAAAAAC-3
PCNA #1 5-GGAGAAAGUUUCAGACUAU-3
PCNA #2 5-GCCGAGAUCUCAGCCAUAU-3JCB • VOLUME 192 • NUMBER 1 • 2011   54
Qin, J., D. Van Buren, H.S. Huang, L. Zhong, R. Mostoslavsky, S. Akbarian, and 
H. Hock. 2010. Chromatin protein L3mbtl1 is dispensable for develop-
ment and tumor suppression in mice. J. Biol. Chem. 285:27767–27775.
Rice, J.C., K. Nishioka, K. Sarma, R. Steward, D. Reinberg, and C.D. Allis. 2002. 
Mitotic-specific  methylation  of  histone  H4  Lys  20  follows  increased   
PR-Set7 expression and its localization to mitotic chromosomes. Genes 
Dev. 16:2225–2230. doi:10.1101/gad.1014902
Rogakou, E.P., D.R. Pilch, A.H. Orr, V.S. Ivanova, and W.M. Bonner. 1998. DNA 
double-stranded breaks induce histone H2AX phosphorylation on serine 
139. J. Biol. Chem. 273:5858–5868. doi:10.1074/jbc.273.10.5858
Schotta, G., R. Sengupta, S. Kubicek, S. Malin, M. Kauer, E. Callén, A. Celeste, 
M. Pagani, S. Opravil, I.A. De La Rosa-Velazquez, et al. 2008. A chromatin-
wide transition to H4K20 monomethylation impairs genome integrity and 
programmed DNA rearrangements in the mouse. Genes Dev. 22:2048–
2061. doi:10.1101/gad.476008
Senga, T., U. Sivaprasad, W. Zhu, J.H. Park, E.E. Arias, J.C. Walter, and A. Dutta. 
2006. PCNA is a cofactor for Cdt1 degradation by CUL4/DDB1-mediated 
N-terminal ubiquitination. J. Biol. Chem. 281:6246–6252. doi:10.1074/
jbc.M512705200
Shi,  X.,  I.  Kachirskaia,  H. Yamaguchi,  L.E.  West,  H.  Wen,  E.W.  Wang,  S. 
Dutta,  E.  Appella,  and  O.  Gozani.  2007.  Modulation  of  p53  func-
tion by SET8-mediated methylation at lysine 382. Mol. Cell. 27:636– 
646. doi:10.1016/j.molcel.2007.07.012
Shibutani, S.T., A.F. de la Cruz, V. Tran, W.J. Turbyfill III, T. Reis, B.A. Edgar, 
and R.J. Duronio. 2008. Intrinsic negative cell cycle regulation provided 
by PIP box- and Cul4Cdt2-mediated destruction of E2f1 during S phase. 
Dev. Cell. 15:890–900. doi:10.1016/j.devcel.2008.10.003
Sørensen, C.S., L.T. Hansen, J. Dziegielewski, R.G. Syljuåsen, C. Lundin, J. 
Bartek, and T. Helleday. 2005. The cell-cycle checkpoint kinase Chk1 is 
required for mammalian homologous recombination repair. Nat. Cell Biol. 
7:195–201. doi:10.1038/ncb1212
Stoyanova, T., N. Roy, D. Kopanja, P. Raychaudhuri, and S. Bagchi. 2009. DDB2 
(damaged-DNA binding protein 2) in nucleotide excision repair and DNA 
damage response. Cell Cycle. 8:4067–4071.
Tardat,  M.,  R.  Murr,  Z.  Herceg,  C.  Sardet,  and  E.  Julien.  2007.  PR-Set7- 
dependent lysine methylation ensures genome replication and stability   
through S phase. J. Cell Biol. 179:1413–1426. doi:10.1083/jcb.200706179
Tardat, M., J. Brustel, O. Kirsh, C. Lefevbre, M. Callanan, C. Sardet, and E. 
Julien. 2010. The histone H4 Lys 20 methyltransferase PR-Set7 regulates 
replication origins in mammalian cells. Nat. Cell Biol. 12:1086–1093. 
doi:10.1038/ncb2113
Trojer, P., G. Li, R.J. Sims III, A. Vaquero, N. Kalakonda, P. Boccuni, D. Lee, 
H. Erdjument-Bromage, P. Tempst, S.D. Nimer, et al. 2007. L3MBTL1, 
a  histone-methylation-dependent  chromatin  lock.  Cell.  129:915–928. 
doi:10.1016/j.cell.2007.03.048
Yang, H., and C.A. Mizzen. 2009. The multiple facets of histone H4-lysine 20 
methylation. Biochem. Cell Biol. 87:151–161. doi:10.1139/O08-131
Zhong, W., H. Feng, F.E. Santiago, and E.T. Kipreos. 2003. CUL-4 ubiquitin 
ligase maintains genome stability by restraining DNA-replication licens-
ing. Nature. 423:885–889. doi:10.1038/nature01747
Ziv, Y., D. Bielopolski, Y. Galanty, C. Lukas, Y. Taya, D.C. Schultz, J. Lukas, 
S.  Bekker-Jensen,  J.  Bartek,  and Y.  Shiloh.  2006.  Chromatin  relax-
ation  in  response  to  DNA  double-strand  breaks  is  modulated  by  a 
novel ATM-  and  KAP-1  dependent  pathway.  Nat.  Cell  Biol.  8:870– 
876. doi:10.1038/ncb1446
Fang,  J.,  Q.  Feng,  C.S.  Ketel,  H.  Wang,  R.  Cao,  L.  Xia,  H.  Erdjument-
Bromage,  P.  Tempst,  J.A.  Simon,  and  Y.  Zhang.  2002.  Purification 
and  functional  characterization  of  SET8,  a  nucleosomal  histone 
H4-lysine  20-specific  methyltransferase.  Curr.  Biol.  12:1086–1099. 
doi:10.1016/S0960-9822(02)00924-7
Fousteri,  M.,  and  L.H.  Mullenders.  2008.  Transcription-coupled  nucleotide   
excision repair in mammalian cells: molecular mechanisms and biologi-
cal effects. Cell Res. 18:73–84. doi:10.1038/cr.2008.6
Goodarzi, A.A., A.T. Noon, D. Deckbar, Y. Ziv, Y. Shiloh, M. Löbrich, and 
P.A.  Jeggo.  2008.  ATM  signaling  facilitates  repair  of  DNA  double-
strand breaks associated with heterochromatin. Mol. Cell. 31:167–177. 
doi:10.1016/j.molcel.2008.05.017
Havens, C.G., and J.C. Walter. 2009. Docking of a specialized PIP Box onto   
chromatin-bound  PCNA  creates  a  degron  for  the  ubiquitin  ligase 
CRL4Cdt2. Mol. Cell. 35:93–104. doi:10.1016/j.molcel.2009.05.012
Houston,  S.I.,  K.J.  McManus,  M.M.  Adams,  J.K.  Sims,  P.B.  Carpenter,   
M.J. Hendzel, and J.C. Rice. 2008. Catalytic function of the PR-Set7   
histone H4 lysine 20 monomethyltransferase is essential for mitotic entry 
and genomic stability. J. Biol. Chem. 283:19478–19488. doi:10.1074/jbc 
.M710579200
Huen, M.S., S.M. Sy, J.M. van Deursen, and J. Chen. 2008. Direct inter-
action  between  SET8  and  proliferating  cell  nuclear  antigen  couples   
H4-K20 methylation with DNA replication. J. Biol. Chem. 283:11073–
11077. doi:10.1074/jbc.C700242200
Jackson, S.P., and J. Bartek. 2009. The DNA-damage response in human biology 
and disease. Nature. 461:1071–1078. doi:10.1038/nature08467
Jackson, S., and Y. Xiong. 2009. CRL4s: the CUL4-RING E3 ubiquitin ligases. 
Trends Biochem. Sci. 34:562–570. doi:10.1016/j.tibs.2009.07.002
Jin, J., E.E. Arias, J. Chen, J.W. Harper, and J.C. Walter. 2006. A family of di-
verse Cul4-Ddb1-interacting proteins includes Cdt2, which is required 
for S phase destruction of the replication factor Cdt1. Mol. Cell. 23:709–
721. doi:10.1016/j.molcel.2006.08.010
Jørgensen, S., I. Elvers, M.B. Trelle, T. Menzel, M. Eskildsen, O.N. Jensen, T. 
Helleday, K. Helin, and C.S. Sørensen. 2007. The histone methyltrans-
ferase SET8 is required for S-phase progression. J. Cell Biol. 179:1337–
1345. doi:10.1083/jcb.200706150
Kim, S.H., and W.M. Michael. 2008. Regulated proteolysis of DNA polymerase 
eta during the DNA-damage response in C. elegans. Mol. Cell. 32:757–
766. doi:10.1016/j.molcel.2008.11.016
Kim, Y., N.G. Starostina, and E.T. Kipreos. 2008. The CRL4Cdt2 ubiquitin li-
gase targets the degradation of p21Cip1 to control replication licensing. 
Genes Dev. 22:2507–2519. doi:10.1101/gad.1703708
Kouzarides, T. 2007. Chromatin modifications and their function. Cell. 128:693–
705. doi:10.1016/j.cell.2007.02.005
Liu, C.L., I.S. Yu, H.W. Pan, S.W. Lin, and H.C. Hsu. 2007. L2dtl is essential for 
cell survival and nuclear division in early mouse embryonic development. 
J. Biol. Chem. 282:1109–1118. doi:10.1074/jbc.M606535200
Liu, W., B. Tanasa, O.V. Tyurina, T.Y. Zhou, R. Gassmann, W.T. Liu, K.A. Ohgi, 
C. Benner, I. Garcia-Bassets, A.K. Aggarwal, et al. 2010. PHF8 mediates 
histone H4 lysine 20 demethylation events involved in cell cycle progres-
sion. Nature. 466:508–512.
Lu, X., M.D. Simon, J.V. Chodaparambil, J.C. Hansen, K.M. Shokat, and K.  
Luger.  2008.  The  effect  of  H3K79  dimethylation  and  H4K20  trimethyl-
ation on nucleosome and chromatin structure. Nat. Struct. Mol. Biol. 15: 
1122–1124. doi:10.1038/nsmb.1489
Margueron,  R.,  and  D.  Reinberg.  2010.  Chromatin  structure  and  the  in-
heritance  of  epigenetic  information.  Nat.  Rev.  Genet.  11:285– 
296. doi:10.1038/nrg2752
Moldovan, G.L., B. Pfander, and S. Jentsch. 2007. PCNA, the maestro of the rep-
lication fork. Cell. 129:665–679. doi:10.1016/j.cell.2007.05.003
Nishioka, K., J.C. Rice, K. Sarma, H. Erdjument-Bromage, J. Werner, Y. Wang, 
S. Chuikov, P. Valenzuela, P. Tempst, R. Steward, et al. 2002. PR-Set7 is 
a nucleosome-specific methyltransferase that modifies lysine 20 of his-
tone H4 and is associated with silent chromatin. Mol. Cell. 9:1201–1213. 
doi:10.1016/S1097-2765(02)00548-8
Nishitani, H., Y. Shiomi, H. Iida, M. Michishita, T. Takami, and T. Tsurimoto. 
2008. CDK inhibitor p21 is degraded by a proliferating cell nuclear antigen- 
coupled Cul4-DDB1Cdt2 pathway during S phase and after UV irradia-
tion. J. Biol. Chem. 283:29045–29052. doi:10.1074/jbc.M806045200
O’Connell, B.C., and J.W. Harper. 2007. Ubiquitin proteasome system (UPS): 
what  can  chromatin  do  for  you?  Curr.  Opin.  Cell  Biol.  19:206–214. 
doi:10.1016/j.ceb.2007.02.014
Oda,  H.,  I.  Okamoto,  N.  Murphy,  J.  Chu,  S.M.  Price,  M.M.  Shen,  M.E. 
Torres-Padilla, E. Heard, and D. Reinberg. 2009. Monomethylation of 
histone H4-lysine 20 is involved in chromosome structure and stabil-
ity and is essential for mouse development. Mol. Cell. Biol. 29:2278– 
2295. doi:10.1128/MCB.01768-08